Beyond the “big pharmas”, the hospitals/clinics and the academic biotech start-ups which most people are familiar with, there is a rich complex world of specialist companies operating in the bioscience and healthcare ecosystem. Each of these business types has its own distinctive opportunities and issues as regards competitive strategy and new value creation. And each may have several alternative business models that could make sense depending on a particular company's circumstances.